Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. |
A: | B: |
PBMCs before separation | Pre-enriched NK cells after depletion of non-NK cells |
Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. | Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. |
C: | D: |
Isolated CD56 +CD8 + NK cells | Isolated CD56 +CD8 – NK cells |
Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. | Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. |
Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. |
A: | B: |
PBMCs before separation | Pre-enriched NK cells after depletion of non-NK cells |
Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. | Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. |
C: | D: |
Isolated CD56 +CD8 + NK cells | Isolated CD56 +CD8 – NK cells |
Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. | Figure 1Both the CD56 +CD8 + and CD56 +CD8 – NK cell subsets were isolated from human PBMCs using the CD56 +CD8 +/CD8 – NK Cell Isolation Kit. Non-NK cells were depleted using an LS Column. The enriched NK cells were magnetically labeled with CD8 MicroBeads, and CD56 +CD8 + NK cells were isolated by positive selection using an MS Column. For isolation of the CD56 +CD8 – NK cells, the wash and the flow-through fraction of the MS Column were further separated using an LD Column and collected in the flow-through. Cells were fluorescently stained with CD8-PE (clone 3G8) and CD56-APC. |
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.